Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for ALR
0.00 (0.00%)
After Hours: 50.35 0.00 (0.00%)
Sep 22, 4:02PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 50.09 - 50.51
52 week 34.41 - 50.64
Open 50.39
Vol / Avg. 1.37M/1.26M
Mkt cap 4.41B
P/E     -
Div/yield     -
EPS -3.11
Shares 87.58M
Beta 0.21
Inst. own 95%
Jul 17, 2017
Quidel Corp Conference Call to Discuss Definitive Agreement To Acquire Alere Triage Assets - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -16.86% -7.90%
Operating margin -5.20% 0.62%
EBITD margin - 14.07%
Return on average assets -6.72% -3.25%
Return on average equity -33.39% -11.93%
Employees 9,700 -
CDP Score - -


51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Officers and directors

Gregg J. Powers Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Namal Nawana President, Chief Executive Officer, Director
Age: 46
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Daniella Cramp Global President - Cardiometabolic Business Unit
Age: 43
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 47
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease Business Unit
Age: 54
Bio & Compensation  - Reuters
Ellen Chiniara J.D. Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, Secretary
Age: 58
Bio & Compensation  - Reuters
Robert Hargadon Senior Vice President - Global Human Resources
Age: 60
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 70
Bio & Compensation  - Reuters
Mark Gladwell Senior Vice President - Global Operations
Age: 42
Bio & Compensation  - Reuters